|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.46 USD | -0.40% |
|
-8.89% | -17.73% |
| Feb. 28 | Transcript : Nautilus Biotechnology, Inc., Q4 2023 Earnings Call, Feb 28, 2024 | |
| Feb. 28 | Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
By Josh Beckerman
Nautilus Biotechnology Inc. shares were recently up 13% to $8.46 after CNBC reported that Amazon.com Inc. had invested in the company.
Amazon had previously disclosed the investment in a Form 13F filing.
Nautilus was briefly paused due to volatility several times Thursday. The life sciences company is focused on technology "for quantifying and unlocking the complexity of the proteome."
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
08-05-21 1536ET
| 1st Jan change | Capi. | |
|---|---|---|
| -17.73% | 308M | |
| -0.10% | 42.07B | |
| +50.98% | 42.16B | |
| +4.43% | 39.77B | |
| -11.36% | 26.68B | |
| +5.67% | 24.68B | |
| -22.84% | 18.68B | |
| -0.20% | 12.11B | |
| +26.30% | 11.99B | |
| +6.91% | 11.06B |
NAUTILUS BIOTECHNOLOGY, INC. 
